![Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial - The Lancet Oncology Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/6675c02e-0aaf-44bb-9407-4829950dba50/gr1.gif)
Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial - The Lancet Oncology
![Outcomes for Participants During Long-Term Follow-Up After Discontinuation of Cabotegravir + Rilpivirine Long-Acting in the Phase 3/3b Clinical Trials Outcomes for Participants During Long-Term Follow-Up After Discontinuation of Cabotegravir + Rilpivirine Long-Acting in the Phase 3/3b Clinical Trials](https://www.natap.org/2021/images/102921/102921-2/1029211.gif)
Outcomes for Participants During Long-Term Follow-Up After Discontinuation of Cabotegravir + Rilpivirine Long-Acting in the Phase 3/3b Clinical Trials
![Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial - ScienceDirect Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719382087-fx1.jpg)
Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial - ScienceDirect
![Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation - Cytotherapy Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation - Cytotherapy](https://www.isct-cytotherapy.org/cms/asset/3d12c911-4cae-456c-93f2-1b3f9bf68bb2/gr1.jpg)
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation - Cytotherapy
![Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41409-021-01258-1/MediaObjects/41409_2021_1258_Fig1_HTML.png)
Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue | Bone Marrow Transplantation
![American Society of Pediatric Nephrology on Twitter: "Long-term follow-up including extensive complement analysis of a pediatric #C3glomerulopathy cohort @Ped_Neph https://t.co/xkFw84734E https://t.co/Bnsil51FZi" / Twitter American Society of Pediatric Nephrology on Twitter: "Long-term follow-up including extensive complement analysis of a pediatric #C3glomerulopathy cohort @Ped_Neph https://t.co/xkFw84734E https://t.co/Bnsil51FZi" / Twitter](https://pbs.twimg.com/media/E-ok6yoX0AELTfN.png)
American Society of Pediatric Nephrology on Twitter: "Long-term follow-up including extensive complement analysis of a pediatric #C3glomerulopathy cohort @Ped_Neph https://t.co/xkFw84734E https://t.co/Bnsil51FZi" / Twitter
![479. Long Term Follow Up of Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpes Virus (Talimogene Laherparepvec, T-VEC) in Patients with Unresectable Metastatic Melanoma: Molecular ... 479. Long Term Follow Up of Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpes Virus (Talimogene Laherparepvec, T-VEC) in Patients with Unresectable Metastatic Melanoma: Molecular ...](https://www.cell.com/cms/attachment/2076207056/2070220886/fx1.jpg)
479. Long Term Follow Up of Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpes Virus (Talimogene Laherparepvec, T-VEC) in Patients with Unresectable Metastatic Melanoma: Molecular ...
![Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper. Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.](https://www.archivesofmedicalscience.com/f/pictures/150321_1fd2f.jpg)
Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.
![Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study - The Lancet Oncology Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/8e4f9307-3e40-4479-9bdc-41e9a0352682/gr1_lrg.jpg)
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study - The Lancet Oncology
![Population Flow sheet. LFUP: Long Term Follow Up completed; LTF: Loss... | Download Scientific Diagram Population Flow sheet. LFUP: Long Term Follow Up completed; LTF: Loss... | Download Scientific Diagram](https://www.researchgate.net/publication/236078955/figure/fig5/AS:341871676149762@1458519967086/Population-Flow-sheet-LFUP-Long-Term-Follow-Up-completed-LTF-Loss-to-follow-up.png)
Population Flow sheet. LFUP: Long Term Follow Up completed; LTF: Loss... | Download Scientific Diagram
![Long-Term Follow-up of Tisagenlecleucel in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Updated Analysis of Juliet Study - Biology of Blood and Marrow Transplantation Long-Term Follow-up of Tisagenlecleucel in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Updated Analysis of Juliet Study - Biology of Blood and Marrow Transplantation](https://www.astctjournal.org/cms/asset/f4e19bb2-19e5-4912-b711-0b87ccca72ad/gr1.jpg)
Long-Term Follow-up of Tisagenlecleucel in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Updated Analysis of Juliet Study - Biology of Blood and Marrow Transplantation
![Zuma-5: long-term follow-up demonstrates substantial and sustained benefit of axicabtagene ciloleucel (axi-cel) for iNHL - Onco Americas Zuma-5: long-term follow-up demonstrates substantial and sustained benefit of axicabtagene ciloleucel (axi-cel) for iNHL - Onco Americas](https://www.oncoamericas.com/wp-content/uploads/2022/02/Zuma-5-long-term-follow-up-demonstrates-substantial-and-sustained-benefit-of-axicabtagene-ciloleucel-axi-cel-for-iNHL-1200x594.jpg)